In this episode, sponsored by Sanofi, we’re joined by Dr. Jiwon Oh to discuss the need to better understand SPMS.

An inside look at Sanofi’s approach to hematology R&D: Q&A with new Global Head of Oncology, Olivier Nataf.

Halting disease progression remains the single greatest unmet need in MS today, and new research points to hidden reasons why disability continues to